logo
logo

Decibio Ventures Invests In Replay’s $55M Seed Funding Round Led By Kkr & Co. And Omx Ventures

Jul 25, 2022•about 3 years ago

Amount Raised

$55 Million

Round Type

seed

Los AngelesGeneticsBiotechnology

Description

DeciBio Ventures, a venture capital firm investing in and advising precision medicine start-ups, invested in the seed funding round for Replay. KKR & Co. Inc. and OMX Ventures led this funding round, which totaled $55 million

Company Information

Company

Replay

Location

Los Angeles, California, United States

About

As part of DeciBio Ventures’ strategy-heavy and supportive VC model, DeciBio Ventures is also providing Replay with ongoing strategic support.Replay’s portfolio of next-generation genomic medicine technologies aims to solve the key challenges currently limiting clinical progress, including the need for increased payload capacity and off-the-shelf cell therapies that substantially reduce cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.Replay’s genomic medicine toolkit comprises several synergistic technology platforms, including:synHSV™ - a high payload capacity HSV vector capable of delivering up to 30x the payload of AAV.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech